A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer’s Disease

Douglas Galasko; Martin R. Farlow; Brendan P. Lucey; Lawrence S. Honig; Donald Elbert; Randall Bateman; Jeremiah Momper; Ronald Thomas; Robert A. Rissman; Judy Pa; Vahan Aslanyan; Archana Balasubramanian; Tim West; Maria Maccecchini; Howard H. Feldman

doi:10.1101/2024.03.20.24304638

Rodneymoore210101sadiegreyxxx720pwebx2 Top <720p>

By breaking down each element, you can quickly gauge whether the file meets your preferences, technical constraints, and legal requirements—without having to open or download it first.

The string